In November, the company also presented new data for the treatment of Demodex blepharitis in patients with Meibomian Gland Disease (MGD). Data showed statistically significant and clinically ...

IRVINE, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management will participate in fireside chats at two upcoming investor conferences: ...

Tarsus Pharmaceuticals is making a splash with Xdemvy, an eye drop that kills the demodex mites that cause inflammation and ...

When managing an irritated cornea, choosing among fortified antibiotics, oral antivirals, anti-inflammatories or combination ...

Carolyn Adelsten woke up feeling like something was in her eye and it wouldn't come out. She visited an eye specialist, got a diagnosis of mild dry eye disease and was told to ...

Bleakley Financial Group LLC bought a new position in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) in the fourth quarter, Holdings Channel reports. The firm bought 5,825 shares ...

In 1999, Edelman founded Perceptive Advisors, a New York-based investment ... This is for the treatment of demodex blepharitis, a common eyelid condition. Aldeyra Therapeutics, Inc. (NASDAQ ...

Fake eyelashes, or eyelash extensions have become a popular cosmetic trend for women as they enhance beauty by giving natural lashes a fuller look. These lashes boost one’s appearance by adding volume ...

Getting the winged eyeliner right – a win. Forgetting to wash off the winged eyeliner before bed – not a win. The truth is, eye makeup, eyeliner, mascara, eyeshadow, can transform your look and give ...